Syntezza Molecular Detection is developing the products of Molecular Detection Inc., a U.S. corporation headquartered in Berwyn, Pennsylvania.
We are introducing a new generation of DNA-based rapid medical tests for the diagnosis of infectious diseases based on our proprietary Syntezza Detect-Ready™ technology platform. The company maintains an R&D and manufacturing operation at the Har Hotzvim Technology Park in Jerusalem, Israel.


